Aktienanalyse zu Auna SA (AUNA)AUNAAuna SA

Auna SA is a Luxembourg-based healthcare company. The Company has a patient- centric model providing prepaid healthcare plans, medical care, and oncology solutions, that promotes integrated healthcare system, healthy lifestyles through prevention, research, and education. It offers a wide-ranging practice and prospects that enables to deliver standard services and the possible patient outcomes. Its network includes nearly 31 healthcare network facilities, consisting of regional network of hospitals, clinics, outpatient, and wellness facilities with a total of 2,308 beds. It is also located in Mexico, Peru, and Colombia. It operates in the Healthcare sector.

Auna SA is currently not a strong buy due to mixed financial indicators and market sentiment. The current price is $5.16, with an RSI of 43.38 indicating potential weakness. Although there was a 9% year-over-year revenue growth reported, the adjusted EBITDA declined by 9% and the net income for Q2 2026 was only $6.5 million, showing volatility in profitability. The main risk is the recent downgrade by analysts, which reflects concerns over the company's financial performance and future earnings potential.